VIPoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Mahshid |
||
| Line 18: | Line 18: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] | |||
Revision as of 17:38, 27 November 2017
|
VIPoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
VIPoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of VIPoma epidemiology and demographics |
|
Risk calculators and risk factors for VIPoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
The incidence of VIPoma is approximately 0.01 per 100,000 individuals worldwide. Women are more commonly affected with VIPoma than men. The incidence of VIPoma increases with age, the median age at diagnosis is 50 years.[1]
Epidemiology and Demographics
- The incidence of VIPoma is approximately 0.01 per 100,000 individuals worldwide.[1]
- Women are more commonly affected with VIPoma than men.[1]
- The incidence of VIPoma increases with age, the median age at diagnosis is 50 years.[1]